BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 16516241)

  • 1. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.
    Miyoshi T; Li Y; Shih DM; Wang X; Laubach VE; Matsumoto AH; Helm GA; Lusis AJ; Shi W
    Life Sci; 2006 Jul; 79(6):525-31. PubMed ID: 16516241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro ATR-FTIR spectroscopic imaging of atherosclerosis: an investigation of the contribution of inducible nitric oxide synthase to lesion composition in ApoE-null mice.
    Palombo F; Shen H; Benguigui LE; Kazarian SG; Upmacis RK
    Analyst; 2009 Jun; 134(6):1107-18. PubMed ID: 19475136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swimming reduces the severity of atherosclerosis in apolipoprotein E deficient mice by antioxidant effects.
    Okabe TA; Shimada K; Hattori M; Murayama T; Yokode M; Kita T; Kishimoto C
    Cardiovasc Res; 2007 Jun; 74(3):537-45. PubMed ID: 17374527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
    Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
    Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet.
    Pejnovic N; Vratimos A; Lee SH; Popadic D; Takeda K; Akira S; Chan WL
    Mol Immunol; 2009 Nov; 47(1):37-45. PubMed ID: 19201478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice.
    Kuhlencordt PJ; Chen J; Han F; Astern J; Huang PL
    Circulation; 2001 Jun; 103(25):3099-104. PubMed ID: 11425775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M; Chen R; Li Z; Shiuchi T; Suzuki J; Ide A; Tsuda M; Okumura M; Min LJ; Mogi M; Horiuchi M
    Circulation; 2005 Sep; 112(11):1636-43. PubMed ID: 16145000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
    J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice.
    Huo Y; Zhao L; Hyman MC; Shashkin P; Harry BL; Burcin T; Forlow SB; Stark MA; Smith DF; Clarke S; Srinivasan S; Hedrick CC; Praticò D; Witztum JL; Nadler JL; Funk CD; Ley K
    Circulation; 2004 Oct; 110(14):2024-31. PubMed ID: 15451785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic backgrounds but not sizes of atherosclerotic lesions determine medial destruction in the aortic root of apolipoprotein E-deficient mice.
    Shi W; Brown MD; Wang X; Wong J; Kallmes DF; Matsumoto AH; Helm GA; Drake TA; Lusis AJ
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1901-6. PubMed ID: 12920047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased levels of lipid peroxidation-induced DNA damage in the onset of atherogenesis in apolipoprotein E deficient mice.
    Godschalk RW; Albrecht C; Curfs DM; Schins RP; Bartsch H; van Schooten FJ; Nair J
    Mutat Res; 2007 Aug; 621(1-2):87-94. PubMed ID: 17418875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(-/-) mice.
    Matsui R; Xu S; Maitland KA; Mastroianni R; Leopold JA; Handy DE; Loscalzo J; Cohen RA
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):910-6. PubMed ID: 16439706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerosis and the protective role played by different proteins in apolipoprotein E-deficient mice.
    Fabrizio Rodella L; Bonomini F; Rezzani R; Tengattini S; Hayek T; Aviram M; Keidar S; Coleman R; Bianchi R
    Acta Histochem; 2007; 109(1):45-51. PubMed ID: 17046051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo.
    Veillard NR; Steffens S; Pelli G; Lu B; Kwak BR; Gerard C; Charo IF; Mach F
    Circulation; 2005 Aug; 112(6):870-8. PubMed ID: 16061736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating adhesion molecules in apoE-deficient mouse strains with different atherosclerosis susceptibility.
    Tian J; Pei H; James JC; Li Y; Matsumoto AH; Helm GA; Shi W
    Biochem Biophys Res Commun; 2005 Apr; 329(3):1102-7. PubMed ID: 15752767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.